14059
Here we studied minimal residual disease ( MRD ) of patients with acute myeloid leukemia ( AML ) who have PML/RAR alpha or AML1/ETO as well as the phenotypic analysis of lymphocyte subsets involved in antitumor immunity .
 ( cell type: lymphocyte subsets, None) , ( protein: PML/RAR alpha, None) , ( protein: AML1/ETO, None) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: RNA,cell type,protein,cell line,DNA, Arguments type: . 
Text: {0} 
Answer:
 ( cell type: lymphocyte subsets, None) , ( protein: PML/RAR alpha, None) , ( protein: AML1/ETO, None) 